Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Michael Behrens

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Virchows Archiv : an International Journal of Pathology|July 24, 2019
Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort studyMatthias Dottermusch, Sandra Krüger, Hans-Michael Behrens, et al.
Histopathology|September 21, 2019
Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus ConferenceDita Ulase, Steffen Heckl, Hans-Michael Behrens, et al.
Cancer Medicine|March 14, 2023
SMARCA4 and SMARCE1 in gastric cancer: Correlation with ARID1A, and microsatellite stability, and SMARCE1/ERBB2 co-amplificationKatharina Pries, Sandra Krüger, Steffen Heckl, et al.
Scientific Reports|February 24, 2023
The tumor biological significance of RNF43 and LRP1B in gastric cancer is complex and context-dependentBente Holm, Stephan Barsuhn, Hans-Michael Behrens, et al.
Virchows Archiv : an International Journal of Pathology|October 11, 2023
MDM2 amplification is rare in gastric cancerSamir Abdullazade, Hans-Michael Behrens, Sandra Krüger, et al.
Oncotarget|September 9, 2017
Troy is expressed in human stomach mucosa and a novel putative prognostic marker of intestinal type gastric cancerFranziska Wilhelm, Christine Böger, Sandra Krüger, et al.
International Journal of Molecular Sciences|March 6, 2021
Gastric Carcinomas with Stromal B7-H3 Expression Have Lower Intratumoural CD8+ T Cell DensityDita Ulase, Hans-Michael Behrens, Sandra Krüger, et al.
Human Pathology|November 10, 2019
Intratumoral heterogeneity and loss of ARID1A expression in gastric cancer correlates with increased PD-L1 expression in Western patientsJulia Maria Tober, Christine Halske, Hans-Michael Behrens, et al.
Virchows Archiv : an International Journal of Pathology|November 27, 2013
Integrins and their ligands are expressed in non-small cell lung cancer but not correlated with parameters of disease progressionChristine Böger, Holger Kalthoff, Simon L Goodman, et al.
Oncotarget|March 25, 2016
PD-L1 is an independent prognostic predictor in gastric cancer of Western patientsChristine Böger, Hans-Michael Behrens, Micaela Mathiak, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Virchows Archiv : an International Journal of Pathology|July 24, 2019
Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort studyMatthias Dottermusch, Sandra Krüger, Hans-Michael Behrens, et al.
Histopathology|September 21, 2019
Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus ConferenceDita Ulase, Steffen Heckl, Hans-Michael Behrens, et al.
Cancer Medicine|March 14, 2023
SMARCA4 and SMARCE1 in gastric cancer: Correlation with ARID1A, and microsatellite stability, and SMARCE1/ERBB2 co-amplificationKatharina Pries, Sandra Krüger, Steffen Heckl, et al.
Scientific Reports|February 24, 2023
The tumor biological significance of RNF43 and LRP1B in gastric cancer is complex and context-dependentBente Holm, Stephan Barsuhn, Hans-Michael Behrens, et al.
Virchows Archiv : an International Journal of Pathology|October 11, 2023
MDM2 amplification is rare in gastric cancerSamir Abdullazade, Hans-Michael Behrens, Sandra Krüger, et al.
Oncotarget|September 9, 2017
Troy is expressed in human stomach mucosa and a novel putative prognostic marker of intestinal type gastric cancerFranziska Wilhelm, Christine Böger, Sandra Krüger, et al.
International Journal of Molecular Sciences|March 6, 2021
Gastric Carcinomas with Stromal B7-H3 Expression Have Lower Intratumoural CD8+ T Cell DensityDita Ulase, Hans-Michael Behrens, Sandra Krüger, et al.
Human Pathology|November 10, 2019
Intratumoral heterogeneity and loss of ARID1A expression in gastric cancer correlates with increased PD-L1 expression in Western patientsJulia Maria Tober, Christine Halske, Hans-Michael Behrens, et al.
Virchows Archiv : an International Journal of Pathology|November 27, 2013
Integrins and their ligands are expressed in non-small cell lung cancer but not correlated with parameters of disease progressionChristine Böger, Holger Kalthoff, Simon L Goodman, et al.
Oncotarget|March 25, 2016
PD-L1 is an independent prognostic predictor in gastric cancer of Western patientsChristine Böger, Hans-Michael Behrens, Micaela Mathiak, et al.
Pageof 7